Regulatory and Policy Considerations

Stanley Wang, MD, JD, MPH | Clinical Cardiovascular Disease, Austin Heart and Assistant Professor of Medicine (Adjunct), University of North Carolina

Collaborating for Cures: Emerging Translational Research in the Stroke and TBI Care Continuum was held at the Shoal Crossing Event Center in Austin, Texas on May 4th. This community education collaboration featured presentations on neuroplasticity, stem cell policy and regulatory issues, neuroimaging techniques and analysis, and provided a forum for leading scientists in the field to share ideas and discuss potential collaborations. Stanley Wang, MD, JD, MPH Director of Legislative Affairs at Austin Heart 
Clinical Cardiovascular Disease, Clinical Cardiologist at Austin Heart South and 
Assistant Professor of Medicine (Adjunct), University of North Carolina shared his personal views on the recent activitites in Texas “Regulatory and Policy Considerations for Adult-Derived Stem Cells.”

Dr. Wang of Austin is a member of the American Heart Association, American Society of Nuclear Cardiology, and Travis County Medical Society. He is a delegate of the Texas Medical Association, a councilor of the Texas Chapter of the American College of Cardiology, and serves on the Texas Medical Board*. Dr. Wang received a bachelor's degree from the University of Texas, a medical degree from the University of Texas Southwestern Medical Center at Dallas, a law degree from the University of Pennsylvania, and a master's degree in public health from the Harvard University School of Public Health.

*Any views or opinions expressed by Dr. Wang are solely his, and are not representative of the Texas Medical Board.

 

Watch This Video:

“Regulatory and Policy Considerations for Adult-Derived Stem Cells”

~

For more information about this program and other Texas Cures Education Foundation supported community outreach initiatives.

Watch Other Videos From the Event:

Senator Kirk Watson Address at Collaborating for Cures Event in Texas “10 Goals in 10 Years”

Regulatory and Policy Considerations for Adult-Derived Stem Cells

The Promise and Challenge of Neuroplasticity

Why Do Clinical Trials in TBI Keep Failing? and What Can We Do About It?